Zang et al. reported that autophagy inhibition allowed NRF2 to exacerbate the progression of diabetic cardiomyopathy in a mouse model, suggesting a complex role for NRF2 in cardiac health (Zang et al., 2020b). Here, NFE2L2 is linked to diabetic cardiomyopathy.